Cancer is malignant tumor, which is a collective term for more than 100 related diseases. When a cell in the body mutates, it divides continuously, out of the body's control, and eventually forms cancer. Prompt diagnosis can go a long way in improving the survival rate of cancer patients.
Head and Neck Tumors |
|
Genitourinary Tumors |
|
Chest Tumors |
|
Gastrointestinal Tumors |
|
Cervical cancer is the most common gynecologic malignancy, mainly caused by human papillomavirus 16/18 (HPV16/18) infection. Early diagnosis of cervical cancer is extremely important and nucleic acid testing is a routine method to identify viral infection and monitor disease progression. Molecular detection tools developed based on the CRISPR-Cas system can be used to detect viruses.
Prostate cancer is one of the most common cancers in men. When prostate cancer is present only in the prostate, it is more likely to be cured if caught early. PSA is a prostate cancer-related marker. Through PSA screening, people with abnormal PSA (PSA>4ng/ml) are screened out. PSA detection can be performed with line immunoassay (LIA), enzyme-linked immunosorbent assay (ELISA), and molecular diagnostic techniques based on the CRISPR-Cas system.
Breast cancer is a malignant tumor that occurs in breast epithelial tissue and is one of the most common tumors in women. Early screening of breast cancer can greatly benefit patients with timely treatment. The diagnosis of breast cancer is the same as other diseases. It needs to be diagnosed through clinical consultation, medical history, direct examination of the patient's breasts and imaging examinations, until the final gold standard pathological examination.
Lung cancer, also known as primary bronchial lung cancer, refers to malignant tumors originating in the trachea, bronchi and lungs. Lung cancer has become the malignant tumor with the highest morbidity and mortality in the world. According to data, there are about 1.825 million new lung cancer patients and 1.6 million new deaths each year.
The timing of disease diagnosis has a significant impact on the survival rate of lung cancer patients. The earlier lung cancer is detected, the higher the survival rate. Therefore, early diagnosis of lung cancer is extremely important.
Gastric cancer is one of the common malignant tumors derived from gastric mucosa epithelial cells, and its morbidity and mortality ranks second among malignant tumors in the world. The 5-year survival rate of early gastric cancer after treatment can reach more than 90%. Therefore, early detection and early treatment are essential to reduce the mortality rate of gastric cancer.
Utilizing the DeteCasTM platform based on the CRISPR-Cas system, CD BioSciences can provide various services in cancer diagnosis, such as nucleic acids detection service, protein biomarker detection service and small molecule detection service. If you are interested in these services, please contact us.
References